This is a Validated Antibody Database (VAD) review about human KIR2DL3, based on 22 published articles (read how Labome selects the articles), using KIR2DL3 antibody in all methods. It is aimed to help Labome visitors find the most suited KIR2DL3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
KIR2DL3 synonym: CD158B2; CD158b; GL183; KIR-023GB; KIR-K7b; KIR-K7c; KIR2DL; KIR2DS5; KIRCL23; NKAT; NKAT2; NKAT2A; NKAT2B; p58

BioLegend
mouse monoclonal (HP-MA4)
  • flow cytometry; human; fig 1e
BioLegend KIR2DL3 antibody (BioLegend, HP-MA4) was used in flow cytometry on human samples (fig 1e). Immun Inflamm Dis (2018) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human; loading ...; fig 5c
BioLegend KIR2DL3 antibody (BioLegend, HP MA4) was used in flow cytometry on human samples (fig 5c). J Immunol (2017) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human; fig 1e
In order to investigate the role of Eomes in the retention of liver natural killer cells, BioLegend KIR2DL3 antibody (BioLegend, HP-MA4) was used in flow cytometry on human samples (fig 1e). J Immunol (2016) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human; loading ...; fig s1
BioLegend KIR2DL3 antibody (BioLegend, HP-MA4) was used in flow cytometry on human samples (fig s1). J Clin Invest (2016) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human; loading ...; fig 6a
BioLegend KIR2DL3 antibody (Biolegend, 339504) was used in flow cytometry on human samples (fig 6a). J Immunol (2016) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human; fig 6
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend KIR2DL3 antibody (Biolegend, HPMA4) was used in flow cytometry on human samples (fig 6). Mucosal Immunol (2016) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human
BioLegend KIR2DL3 antibody (BioLegend, HPMA4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human
BioLegend KIR2DL3 antibody (BioLegend, HPMA4) was used in flow cytometry on human samples . Clin Cancer Res (2013) ncbi
R&D Systems
mouse monoclonal (143211)
R&D Systems KIR2DL3 antibody (R&D Systems, 143211) was used . Nat Commun (2020) ncbi
mouse monoclonal (180704)
R&D Systems KIR2DL3 antibody (R&D Systems, 180704) was used . Nat Commun (2020) ncbi
Invitrogen
mouse monoclonal (HP-MA4)
  • flow cytometry; human
Invitrogen KIR2DL3 antibody (eBioscience, HP-MA4) was used in flow cytometry on human samples . Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (HP-MA4)
  • flow cytometry; human
In order to quantify coexpression of different killer Ig-like molecules in patient natural killer cells with mutant TAP genes mediating deficient HLA class I expression, Invitrogen KIR2DL3 antibody (eBioscience, HP-MA4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
Beckman Coulter
mouse monoclonal (EB6B)
  • flow cytometry; human; loading ...; fig s2b
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, EB6B) was used in flow cytometry on human samples (fig s2b). J Infect Dis (2019) ncbi
mouse monoclonal (EB6B)
  • flow cytometry; human; loading ...; fig 5a
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, A66899) was used in flow cytometry on human samples (fig 5a). J Immunol (2018) ncbi
mouse monoclonal (EB6B)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, EB6) was used in flow cytometry on human samples (fig s1). Eur J Immunol (2018) ncbi
mouse monoclonal (EB6B)
  • flow cytometry; human; loading ...; fig 3b
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, EB6B) was used in flow cytometry on human samples (fig 3b). Immun Ageing (2017) ncbi
mouse monoclonal (EB6B)
  • flow cytometry; human
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, EB6) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (EB6B)
  • flow cytometry; human; fig 2
Beckman Coulter KIR2DL3 antibody (Beckman Coulter, EB6.B) was used in flow cytometry on human samples (fig 2). Eur J Immunol (2015) ncbi
BD Biosciences
mouse monoclonal (DX27)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences KIR2DL3 antibody (BD Pharmingen, DX27) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences KIR2DL3 antibody (BD Pharmingen, HP-3E4) was used in flow cytometry on human samples (fig 5a). Front Immunol (2019) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; loading ...; fig s2j
BD Biosciences KIR2DL3 antibody (BD Biosciences, HP-3E4) was used in flow cytometry on human samples (fig s2j). JCI Insight (2017) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences KIR2DL3 antibody (BD Biosciences, HP-3E4) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences KIR2DL3 antibody (BD, 556063) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (DX27)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences KIR2DL3 antibody (BD, 556071) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; fig 6
BD Biosciences KIR2DL3 antibody (BD Bioscience, 556063) was used in flow cytometry on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (HP-3E4)
  • flow cytometry; human; tbl s5
In order to investigate when Vgamma9Vdelta2 T cells develop, BD Biosciences KIR2DL3 antibody (BD Bioscience, HP-3E4) was used in flow cytometry on human samples (tbl s5). Proc Natl Acad Sci U S A (2015) ncbi
Articles Reviewed
  1. Tseng H, Xiong W, Badeti S, Yang Y, Ma M, Liu T, et al. Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma. Nat Commun. 2020;11:4810 pubmed publisher
  2. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  3. van Erp E, Feyaerts D, Duijst M, Mulder H, Wicht O, Luytjes W, et al. Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function. J Infect Dis. 2019;219:723-733 pubmed publisher
  4. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed publisher
  5. Pugh J, Nemat Gorgani N, Norman P, Guethlein L, Parham P. Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage. J Immunol. 2018;200:1146-1158 pubmed publisher
  6. Hydes T, Noll A, Salinas Riester G, Abuhilal M, Armstrong T, Hamady Z, et al. IL-12 and IL-15 induce the expression of CXCR6 and CD49a on peripheral natural killer cells. Immun Inflamm Dis. 2018;6:34-46 pubmed publisher
  7. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed publisher
  8. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  9. van der Geest K, Wang Q, Eijsvogels T, Koenen H, Joosten I, Brouwer E, et al. Changes in peripheral immune cell numbers and functions in octogenarian walkers - an acute exercise study. Immun Ageing. 2017;14:5 pubmed publisher
  10. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  11. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  12. Landtwing V, Raykova A, Pezzino G, Beziat V, Marcenaro E, Graf C, et al. Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest. 2016;126:3772-3782 pubmed publisher
  13. Reches A, Nachmani D, Berhani O, Duev Cohen A, Shreibman D, Ophir Y, et al. HNRNPR Regulates the Expression of Classical and Nonclassical MHC Class I Proteins. J Immunol. 2016;196:4967-76 pubmed publisher
  14. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  15. Zou Y, Bao J, Pan X, Lu Y, Liao S, Wang X, et al. NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure. PLoS ONE. 2015;10:e0134568 pubmed publisher
  16. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  17. Dimova T, Brouwer M, Gosselin F, Tassignon J, Leo O, Donner C, et al. Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proc Natl Acad Sci U S A. 2015;112:E556-65 pubmed publisher
  18. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed publisher
  19. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  20. Miller J, Rooney C, Curtsinger J, McElmurry R, McCullar V, Verneris M, et al. Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy. Biol Blood Marrow Transplant. 2014;20:1252-7 pubmed publisher
  21. Sleiman M, Brons N, Kaoma T, Dogu F, Villa Forte A, Lenoble P, et al. NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules. J Immunol. 2014;192:2602-10 pubmed publisher
  22. Wiernik A, Foley B, Zhang B, Verneris M, Warlick E, Gleason M, et al. Targeting natural killer cells to acute myeloid leukemia in vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition. Clin Cancer Res. 2013;19:3844-55 pubmed publisher